Study of 124I-NM404 in Advanced Solid Malignancies
by on Friday, August 10th, 2012 | No Comments
Condition: Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer
Intervention: Drug: 124I-NM404
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Novelos Therapeutics
Recruiting – verified August 2012
The rest is here: Study of 124I-NM404 in Advanced Solid Malignancies